1Milleron B, Mornex F, Martin E,et al. Preoperative chemotherapy and chemoradiotherapy for non-small-cell bronchial cancers. Cancer Radiother,2002,6 ( Suppl 1 ): 105s- 113s.
2Edelman MJ. Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects. Expert Opin Pharmacother,2003,4 ( 6 ): 843-852.
3Ichinose Y,Fukuyama Y,Asoh H,et al. Induction chemoradiotherapy and surgical resection for selected stage ⅢB non-small-cell lung cancer. Ann Thorac Surg,2003,76(6) :1810-1814.
4Machtay M,Lee JH,Stevenson JP,et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage Ⅲ nonsmall cell lung carcinoma: Long-term results and associations with pathologic response. J Thorac Cardiovasc Surg,2004,127 ( 1 ): 108-113.
5Wirth LJ, Lucca J, Ostler P,et al. Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage Ⅲ non- small cell lung cancer: a Phase Ⅰ study. Clin Cancer Res, 2003,9 ( 5 ): 1698 - 1704.
6Cesario A, Margaritora S,Trodella L, et al. Incidental surgical findings of a phase Ⅰ trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer. Lung Cancer,2002,37 (2) :207-212.
7van Putten JW, Price A, van der Leest AH,et al. A Phase I study of gemcitabine with concurrent radiotherapy in stage Ⅲ,locally advanced non-small cell lung cancer. Clin Cancer Res, 2003,9 (7):2472-2477.
8Rakovitch E,Tsao M, Ung Y, et al. Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-smallcell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys,2004,58( 1 ) :196-203.
9Yoshizawa H, Tanaka J, Kagamu H, et al. Phase Ⅰ/Ⅱ study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non- small- cell lung cancer. Br J Cancer, 2003,89 ( 5 ):803-807.
10Groen HJ,van der Leest AH, Fokkema E,et al. Continuously infused carboplatin used as radiosensitizer in locally unresectable nonsmall-cell lung cancer: a multicenter phase Ⅲ study. Ann Oncol,2004,15 (3) :427-432.
7Pfister DG, Johnson DH, Azzoli CG, et al. American society of clinical oncology treatment of unresecable non-small cell lung cancer guideline: update. J Clin Oncol, 2004, 22:330-353.
8Jeremic B, Machtay M. Concurrent radiochemotherapy in the treatment of locally advanced non-small cell lung cancer. Hematol Oncol Clin North Am,2004,18( 1 ) :91-100.
9Bissett D,Setanoians A,Casidy J,et al.Phase I and pharmacokinetic study of taxotere(RP56976) administered as a 24-hour infusion[J]. Cancer Res, 1993,53(3 ):523-527.
10Wanger ILl.Radiation therapy in the manngemengt of patients with unresectable stage ~I a And III b non small cell lung cancer[J]. Semin Onco, 1997,24(4):423-428.
